Company Description
Canton Strategic Holdings, Inc. engages in the institutional blockchain adoption and digitization of financial markets in the United States.
It operates in two segments, Digital Asset Treasury and Clinical Stage Bio-technology. The company is involved in the operation of Canton Coin-centric digital asset treasury strategies, including validator operations and network participation; application support and strategic investments; collaboration and ecosystem advancement; capital raising and treasury expansion; token management - locking, lending, and options; Canton Foundation; and governance and risk management.
It also researches and develops GV104, a buccal film formulation of nalmefene for the treatment of respiratory depression and prophylactic protection against synthetic opioid exposure in military and first responders; and GV023, an oral anti-tumor necrosis factor-alpha monoclonal antibody that addresses critical limitation of IV gold standard for the treatment of repeated intravenous infusions.
The company was formerly known as Tharimmune, Inc. and changed its name to Canton Strategic Holdings, Inc. in February 2026.
Canton Strategic Holdings, Inc. was incorporated in 2017 and is headquartered in Red Bank, New Jersey.
| Country | United States |
| Founded | 2017 |
| IPO Date | Jan 12, 2022 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 12 |
| CEO | Mark Wendland |
Contact Details
Address: 34 Shrewsbury Avenue, Suite 1C Red Bank, New Jersey 07701 United States | |
| Phone | 732 889 3111 |
| Website | cantonstrategic.com |
Stock Details
| Ticker Symbol | CNTN |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 1861657 |
| CUSIP Number | 432705309 |
| ISIN Number | US4327053090 |
| Employer ID | 84-2642541 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Mark Wendland | Chief Executive Officer and Chairman of the Board |
| Mark Toomey | President |
| Jacob Asbury | Chief Financial Officer |
| Angela Dominy Radkowski | Chief Operating Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 13, 2026 | 10-Q | Quarterly Report |
| May 11, 2026 | SCHEDULE 13G/A | Filing |
| Apr 15, 2026 | D | Notice of Exempt Offering of Securities |
| Apr 15, 2026 | D | Notice of Exempt Offering of Securities |
| Mar 31, 2026 | 10-K | Annual Report |
| Mar 31, 2026 | 8-K | Current Report |
| Mar 11, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Mar 3, 2026 | 8-K | Current Report |
| Mar 3, 2026 | 424B5 | Filing |
| Mar 3, 2026 | 8-K | Current Report |